Organogenesis Holdings
ORGO
18 hedge funds and large institutions have $136M invested in Organogenesis Holdings in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 3 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
25% more capital invested
Capital invested by funds: $109M → $136M (+$27.6M)
6% more funds holding
Funds holding: 17 → 18 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$20.6M |
| 2 |
GCL
Glazer Capital LLC
New York
|
+$9.89M |
| 3 |
LIM
Longfellow Investment Management
Boston,
Massachusetts
|
+$3.34M |
| 4 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
+$1.97M |
| 5 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$1.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HHC
Hutchin Hill Capital
New York
|
-$14.7M |
| 2 |
CI
Cowen Inc
New York
|
-$575K |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$439K |
| 4 |
BCM
Bluefin Capital Management
New York
|
-$369K |
| 5 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
-$35K |
ORGO Hedge Fund Activity: Q2 2017 in Review
18 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q2 2017, worth a combined $136M — up 25% from $109M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ORGO positions and 3 closed out — a net gain of 1 holder — while 5 added to existing stakes and 2 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $20.6M. The largest seller was Hutchin Hill Capital, exiting entirely with an estimated $14.7M sold.
- 18 institutional investors held Organogenesis Holdings (ORGO) as of Q2 2017, up from 17 in Q1 2017.
- Funds reported $136M of Organogenesis Holdings stock for Q2 2017, up 25% quarter-over-quarter.
- 4 funds opened new Organogenesis Holdings positions in Q2 2017 and 3 closed out, a net change of +1 holder.
- The largest Organogenesis Holdings buyer in Q2 2017 was Alyeska Investment Group, an estimated $20.6M added.
- The largest Organogenesis Holdings seller in Q2 2017 was Hutchin Hill Capital, an estimated $14.7M sold.
Based on aggregated 13F filings for Q2 2017.